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INTRODUCTION
Adult mesenchymal stem cells (MSCs) are a promising cell source for regenerative medicine due to their multipotent differentiation capacity [1] and immunomodulatory properties [2] . Controlling the phenotype of MSCs is a central challenge in tissue engineering and regenerative medicine. The fate of progenitor cells can potentially be modulated through the introduction of exogenous genes for the cell-mediated synthesis of specific proteins. This approach may be preferable over the delivery of recombinant cytokines and growth factors which involves the administration of non-physiological concentrations, due to the short half-life and fast body clearance and a lower therapeutic effect in comparison to natural proteins [3] [4] [5] . A variety of genes have been explored to this end, including members of the transforming growth factor-beta (TGF-β) superfamily of proteins such as bone morphogenic protein 2 (BMP2) and transforming growth factor-beta 3 (TGF-β3), whose overexpression has been previously reported to enhance bone and cartilage regeneration in vivo [6] [7] [8] . But the success of gene therapy ultimately depends on the gene delivery mechanism to maximise nucleic acid uptake and, consequently, downstream protein production [3, 4, [9] [10] [11] .
Traditionally, viral vectors such as retrovirus, lentivirus and adenovirus, have been used for the delivery of genes into cells via a process known as transduction [10, 12, 13] . Although they offer high transduction efficiencies and stable gene expression, many limitations remain associated with viral vectors [14] [15] [16] such as insertional mutagenesis [17] , immunogenicity [11] , limited DNA packaging capacity [18] and cumbersome large-scale production [19] . Non-viral gene carriers are promising alternatives for gene delivery and have the potential to address these limitations [9] .
Moreover, the transient expression associated with these systems can be more compatible with the natural wound healing processes [20] . Several non-viral vectors are commonly used for gene delivery, including lipids, polymers, cell penetrating peptides (CPPs) and inorganic nanoparticles [13] . While such systems can be used to efficiently transfect cells with specific genes, the effects that these nonviral vectors have on stem cell fate remains relatively unknown [21, 22] .
Cationic lipid-based and polymeric DNA vectors such as lipofectamine and polyethylenimine (PEI) are amongst the most widely used non-viral gene delivery methods [13, 22, 23] , and are often used as a gold standard for non-viral gene transfection [3] . However their potential cytotoxicity [13, 24] and sensitivity to media supplementation with serum and antibiotics [25] limits their use in tissue engineering applications. Among alternative options, inorganic nanoparticles made of calcium phosphate, gold or silica, have been drawing attention for their use in tissue engineering due to their biocompatibility, wider availability, long-term stability, ease of preparation and low toxicity [3, [26] [27] [28] .
More recently, different classes of peptides [29, 30] , such as the RALA amphipathic peptide (RALA) comprised of repeating arginine/alanine/leucine/alanine units [30] , have been developed as novel nucleic acid carriers [31, 32] , showing excellent cytocompatibility and moderate transfection efficiencies in vivo and in vitro [30, 33] . These non-viral delivery vehicles are promising in terms of compatibility and transfection efficiency, however the suitability of a gene delivery vector for stem cell-mediated tissue engineering is not only determined by its transfection efficiency, cytocompatibility and levels of expression of the gene product, but also by its chemical composition and how the intracellular delivery of such nanomaterials may influence stem cell fate [22] .
Therefore, the objective of this study was to first compare the capacity of three different classes of non-viral gene delivery vectors (PEI, nanohydroxyapatite (nHA) and RALA) to transfect bone marrow-derived MSCs. The impact of intracellular delivery of such nanomaterials on the viability, cytoskeletal structure and multi-lineage differentiation potential of MSCs was assessed. We then used these vectors to deliver BMP2 and TGF-β3 genes to MSCs as a means to promote either osteogenesis or chondrogenesis in a 2D or 3D environment, and investigated the influence of different gene carriers on MSC lineage commitment. Collectively the results of this study demonstrate that gene vectors with comparable capacities to transfect MSCs with reporter and therapeutic genes can have dramatically different effects on MSC differentiation.
MATERIALS AND METHODS

Plasmid propagation
Four different plasmids were used in the current study: two plasmids encoding for the reporter genes green fluorescent protein (pGFP, Amaxa, Lonza Cologne AG, Germany) and luciferase (pLUC, pGaussia Luciferase; New England Biolabs, Massachusetts, USA), and another two encoding for the therapeutic genes BMP2 (donation from Prof. Kazihusa Bessho, Kyoto University, Japan) and TGF-β3 (InvivoGen, Ireland). Plasmid amplification was performed by transforming chemically competent Escherichia coli bacterial cells (One Shot TOP10; Biosciences, Ireland) according to the manufacturer's protocol. The transformed bacteria were cultured on LB plates with 50 mg/L kanamycin (Sigma-Aldrich, Ireland) as the selective antibiotic for pGFP and 100 mg/L ampicillin (Sigma-Aldrich, ireland) as the selective antibiotic for pLUC, pTGF-β3, and pBMP2. Bacterial colonies were harvested and inoculated in LB broth (Sigma-Aldrich, Ireland) and incubated overnight for further amplification. The harvested bacterial cells were then lysed, and the respective pDNA samples were purified using qiagen plasmid kit (MaxiPrep Kit; Qiagen, Ireland). Nucleic acid concentration (ng/µL) was determined by analyzing the 260:280 ratio and 230 nm measurement using NanoDrop spectrophotometer (Labtech International, Uckfield, UK). Plasmids in this study were used at a concentration of 0.5 µg plasmid in 1 µL Tris-EDTA (TE) buffer.
Preparation of delivery vectors and vector-pDNA complexes
The synthesis of the nHA particles was performed as previously described [34] . Briefly, a solution of 12 mM sodium phosphate (Sigma-Aldrich, Ireland), containing 0.017% DARVAN821A (RTVanderbilt, Norwalk, USA) was added to an equal volume of a 20 mM calcium chloride solution (Sigma-Aldrich, Ireland) and filtered through a 0.2 mm filter (Fisher, Ireland). nHA-pDNA complexes were prepared by adding 150 µL of the nHA solution to 2 µg of pDNA pretreated with 0.25 M CaCl2 (Sigma-Aldrich, Ireland) as previously optimized [26, 27] . The nHA-pDNA solutions were not incubated prior to transfection in order to avoid particle aggregation that could impair cellular uptake as previously optimized [26] .
PEI-pDNA complexes were prepared using branched PEI with a molecular weight of 25kDA (SigmaAldrich, Ireland). PEI was condensed with pDNA in an N:P ratio (the molar ratio of positively charged nitrogen atoms in the PEI to negatively charged phosphates in the pDNA backbone) of 7, a ratio previously optimized for MSC transfection [35] . The PEI-pDNA solution was then incubated for 30 minutes for complex formation.
The RALA peptide was synthesised as previously described [30] . Briefly, the peptide was produced by 9-fluorenylmethyloxycarbonyl (Fmoc) solid-state peptide synthesis (Biomatik, USA) and supplied as a desalted, lyophilised powder. The product was purified and validated by reversed-phase highperformance liquid chromatography (RPHPLC); molecular mass was confirmed as 3327.98. The RALApDNA complexes were prepared at N:P ratio of 6, previously optimized to achieve low cytotoxicity and high transfection efficiency [30, 33] . The RALA-pDNA solution was then incubated for 30 minutes for complex formation.
Determination of size and zeta potential of the nanoparticles-pDNA complexes
The morphology of the nHA-pDNA, PEI-pDNA and RALA-pDNA complexes were characterized using transmission electron microscopy (TEM). The nHA-pDNA sample was prepared by placing 5 µL droplet onto a Formvar/SiO TEM Cu grid (Agar Scientific, UK) and allowed to air dry overnight. Similarly, the PEI-pDNA and RALA-pDNA were prepared on holey-carbon film Cu TEM grids and post-stained with 5% uranyl acetate as previously described [30] . nHA-pDNA and PEI-pDNA vectors were characterized using an FEI Titan TEM (FEI, USA) operating at 300 kV. RALA-pDNA was characterized using a JEOL CXII TEM (JEOL, USA) operating at 80 kV. The size and zeta potential of the complexes were assessed using a Nano ZS Zetasizer and DTS software (Malvern Instruments, UK).
Isolation and expansion of bone marrow-derived MSCs
Bone marrow-derived MSCs were isolated from the femora of porcine donors (3-4 months, >50 Kg) within 3 h of sacrifice according to a modified method developed for human MSCs [36] , residual complexes were removed after 4 h of incubation and replaced with standard culture media.
Assessment of transfection efficiency
In order to evaluate the transfection efficiency, pDNA encoding the GFP gene was prepared, complexed with each of the three vectors (section 2.2) and MSCs were transfected as described above.
Transfection efficiency was determined by quantifying the percentage of green fluorescent cells at days 3 and 7 post transfection using flow cytometry (BD FACSCALIBUR system, BD Biosciences, UK).
Assessment of cell viability and metabolic activity
After 1 and 3 days of nHA-, PEI-or RALA-mediated gene delivery, metabolic activity of treated cells was evaluated using standard Alamar Blue (Biosciences, Ireland) assay. For the assay, cell culture media from the wells was replaced, at specific time points, with 10% Alamar Blue containing standard culture media (1 mL/well) and were incubated for 4 h at 37 °C. After the incubation time, 200 µL of the supernatant was plated in triplicate into a 96-well plate; absorbance was read at 570 and 600 nm using a plate reader (Bioteck, Instruments Inc, UK). Optical density of the media was translated to cell metabolic activity relative to the untransfected control as previously described [37] .
Fluorescent imaging and cell morphology analysis
Qualitative and semi-quantitative analysis of cell morphology was performed on nHA-pGFP, PEI-pGFP and RALA-pGFP transfected cells. Cells were imaged at day 1 and 3 after transfection using an inverted epifluorescent microscope (Olympus IX83, Germany). Cell morphology was assessed semiquantitatively through the calculation of the cell surface area, aspect ratio and circularity using ImageJ software, n = 4 and 6 pictures per sample. Ireland) for 10 min at RT, washed in PBS and were imaged using confocal microscopy (Leica SP8, Ireland).
Osteo-adipo and chondrogenic differentiation of MSCs
For evaluating osteo-adipo lineage differentiation of MSCs, transfected MSCs and the non-treated controls were maintained in standard culture media for a period of 24 h followed by 14 days in osteoadipo bi-potent media at 20% O2 and 37 o C. Osteo-adipo bi-potent media [38] was prepared by mixing osteogenic media (standard culture media containing β-glycerolphosphate (10 mM), dexamethasone (100 nM) and L-ascorbic acid-2-phosphate (0.05 mM) with adipogenic media (standard culture media containing dexamethasone (100 mM), isobutyl-1-methyl xanthine (IBMX) (0.5 mM) and indomethacin (50 µM) (all from Sigma-Aldrich, Ireland) at 1:1 ratio. Culture media was replaced twice weekly.
Negative controls (untransfected and transfected cells in standard culture media) were also maintained in parallel.
For evaluating chondrogenic differentiation of MSCs, transfected MSCs and the non-treated controls maintained in standard culture media for a period of 24 h were pelletized by centrifugation at 2000 rpm at a cell density of 250 x 10 3 cells/pellet. Pellets were maintained in a chemically defined medium consisting of DMEM GlutaMAX supplemented with penicillin (100 U/mL)-streptomycin (100 mg/mL), 100 mg/mL sodium pyruvate, 40 mg/mL l-proline, 50 mg/mL l-ascorbic acid-2-phosphate, 1.5mg/mL BSA, 1 x insulin-transferrin-selenium, and 100 nM dexamethasone (all from Sigma-Aldrich, Ireland)
at 20% pO2 and 37 °C for a period of 21 days. Half media changes (only half the media was changed)
were performed twice weekly. No exogenous recombinant growth factors were added to the culture media.
Gene expression analysis
Transfected and control cells after 7 days of in vitro culture were lysed using R lysis buffer (Qiagen, UK) supplemented with 10 µL mL -1 β-mercaptoethanol (Sigma-Aldrich, Ireland) and stored at -80°C.
Lysates were thawed and homogenized using a QIAshredder column (Qiagen, UK) and total RNA was isolated and purified using the RNeasy mini kit (Qiagen, UK) using the manufacturer suggested protocol. Purity and yield of RNA was quantified using the NanoDrop Spectrophotometer (Labtech International, Uckfield, UK). For cDNA preparation, 50 ng total RNA of each sample was reverse transcribed into cDNA per 20 μL of reaction volumes using the high capacity reverse transcription cDNA kit (Applied Biosystems, Paisley, UK) as per manufacturer's instructions. Quantitative PCR was performed using an ABI 7500 sequence detection system (Applied Biosystems, Paisley, UK) and SYBR select master mix (Applied Biosystems, Paisley, UK) for evaluating the expression SRY-box-9 (SOX9), Runt related transcription factor 2 (RUNX2), Aggrecan (ACAN), and Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) genes. Primer sequences that were used for amplification of these genes are listed in Table 1 . Comparative Threshold (cT) data were analysed using the ΔΔCT method as described previously [39] with GAPDH as the endogenous control. Relative expression of the genes is presented as fold changes relative to the control group. The levels of BMP2 and TGF-β3 in the culture medium expressed by nHA, PEI and RALA transfected MSCs were quantified using ELISAs (R&D Systems). The cell culture supernatant was collected and analyzed at day 3 and 7. Assays were carried out according to the manufacturer's instructions, and the absorbance of each sample was read at 450 nm using a plate reader, whereby the quantity of either BMP2 or TGF-β3 protein present was deduced by calculating against a standard curve.
Quantitative biochemical analysis
Monolayers were lysed using Cell Lytic (Sigma-Aldrich, Ireland) and pellets were digested with papain (125 mg/mL, pH 6.5) in 0. to dry, and analyzed using a chloramine-T assay [40] with a hydroxyproline-to-collagen ratio of 1:7.69 [41] . Four samples per group were analyzed for each biochemical assay.
Histological and immunohistochemical analysis
To evaluate mineral deposition, cells in monolayer culture at day 14 were fixed in 100% ethanol and stained with 1% alizarin red (AR) (Sigma-Aldrich, Ireland). Stained samples were air dried and images were captured using phase transmission microscope (Olympus, UK). Semi-quantitative analysis of AR staining was done through extraction of the dye using 10% cetylpyridinium chloride (Sigma-Aldrich, Ireland) and measuring the absorbance at 540 nm [42] .
For evaluating oil droplets, cells were fixed in 4% PFA and stained with Oil-Red-O (ORO) at day 14.
Semi-quantitative analysis of ORO staining was done through extraction of the dye using 100%
isopropanol (Sigma-Aldrich, Ireland) and measuring the absorbance at 490 nm.
For evaluating sGAG, calcium and collagen deposition, cell pellets were fixed with 4% PFA after 21
days in vitro, wax embedded, sliced (8 µm) and mounted on microscopic slides. The sections were stained with 1% AR to assess calcium accumulation and Alcian blue (Sigma-Aldrich, Ireland) to assess sGAG content. Collagen types I, II and X were evaluated using a standard immunohistochemical technique as described previously [43] . Negative (porcine cartilage and ligament for collagen type X, and growth plate for collagen type I and II) and positive controls (cartilage for collagen type II, ligament for collagen type I and growth plate for collagen type X) were included for each immunohistochemical analysis.
Statistical analysis
Statistical analyses were performed using GraphPad Prism (version 5) software. One-way ANOVA was used for analysis of variance with Tukey's post hoc test to compare between groups. Numerical and graphical results are displayed as mean ± standard deviation. Significance was accepted at a level of p < 0.05.
RESULTS
Particle size and Zeta potential of the nHA-pGFP, PEI-pGFP and RALA-pGFP complexes
Following conjugation with pGFP, the nHA, PEI and RALA complexes were found to be of different size (Fig.1A) , charge (Fig.1B) and shape (Fig.1C, D and E) . nHA-pGFP complexes were on average larger in size (~300 nm) and had a negative zeta potential. In contrast, the PEI-pGFP and RALA-pGFP complexes were smaller (>150 nm) and had a positive charge. TEM analysis showed aggregation of the nHA-pGFP complexes (Fig.1.C) , while PEI-pGFP (Fig.1.D) and RALA-pGFP ( Fig.1.E at day 3 ( Fig.2.A) . However, 7 days after treatment, the percentage of GFP positive cells decreased in the nHA and RALA transfected groups while it stayed constant in the PEI group (Fig.2.A) . The metabolic activity of treated cells significantly decreased in the PEI group at day 1 in comparison to the RALA and nHA groups (Fig.2B) . GFP positive cells were imaged at day 1 and 3 after transfection (Fig.2C ) and the cell surface area (Fig.2.D) , circularity ( Fig.2 .E) and cell aspect ratio ( Immunofluorescent imaging of cells treated with either nHA, PEI or RALA, complexed to pDNA encoding for luciferase (pLUC) and stained for vinculin (green), F-actin (red) and nuclei (blue), revealed the presence of more well developed and intensely stained actin stress fibers and a higher number of mature focal adhesions in the nHA (Fig.3 .B and F) and RALA (Fig.3 .D and H) in comparison to PEI transfected MSCs (Fig.3 . C and G). It also confirmed the effects of PEI on cell morphology, where MSCs appeared smaller with minimal spreading in comparison to the elongated MSCs when nHA and RALA were used as gene delivery vectors (Fig.3) .
The choice of gene delivery vector influences osteo-adipo lineage specification in MSCs
Delivery of plasmid DNA encoding for the reporter gene GFP (pGFP) to MSCs in 2D culture resulted in significantly enhanced calcification (Fig. 4 .A and D) when nHA and RALA were used as transfection vectors in comparison to the PEI transfected group and untransfected controls after 14 days maintained in mixed osteo-adipo media. In both the nHA and RALA transfected groups, GFP positive cells formed aggregates at day 14 ( Fig.4.C) confirming the presence of transfected cells in the mineralized nodules observed after calcium staining (Fig.4.A) . In contrast, the PEI transfected cells tended to undergo adipogenesis, as demonstrated by a higher presence of lipid granules in comparison to the control and the nHA and RALA groups (Fig.4 .B and E). No mineralized nodules were observed in PEI transfected cells (Fig.4 .A and C).
Osteogenesis of MSCs after therapeutic gene delivery is highly dependent on the choice of gene delivery vector and does not correlate with therapeutic protein production
Therapeutic gene delivery of pDNA encoding for either TGF-β3 or BMP2 in combination or isolation to MSCs in 2D culture resulted in effective protein production using the three vectors (Fig.5.A and B) .
At day 3, the highest levels of protein were produced using RALA and PEI as the delivery vector, while at day 7 the highest levels were observed with PEI with low levels of protein production measured using nHA or RALA as the delivery vector (Fig.5.A and B) . Although nHA-mediated transfection led to significantly lower overall levels of TGF-β3 (Fig.5 .A) and BMP2 protein production ( Fig.5.B) , it resulted in the highest levels of mineral deposition after 14 days of 2D in vitro culture under basal media conditions in comparison to the RALA and PEI groups and the nHApGFP control (Fig.5.C and D) .
Chondrogenesis of MSCs after delivery of TGF-β3 and BMP2 plasmid DNA is highly dependent on the choice of gene delivery vector
MSCs transfected using the previously described non-viral gene delivery vectors complexed to pDNA encoding for the therapeutic genes TGF-β3 or BMP2 in combination or isolation were used to produce pellets and cultured within basal, chemically defined media conditions for 21 days. PCR analysis of gene expression at day 7 showed increased expression of the early chondrogenic differentiation marker SOX9 [44, 45] in the nHA and RALA pTGF-β3-pBMP2 co-delivery group and in the RALA-BMP2 group in comparison to the PEI treated MSCs (Fig.6.A) . The MSCs transfected with RALA-pBMP2 and RALA-pTGF-β3-pBMP2 expressed increased levels of ACAN (a protein that forms an integral part of the extracellular matrix in cartilaginous tissue) compared to the other groups ( Fig.6.B ).
RUNX2, a marker of endochondral ossification, was expressed at higher levels in the RALA-TGF-β3 and nHA-TGF-β3 groups compared to when pBMP2 and pTGF-β3 were co-delivered using these vectors ( Fig.6 .C). The SOX9:RUNX2 ratio (a predictor of the osteogenic potential of MSCs where a higher value suggests a more stable chondrogenic phenotype [44, 46] ) was also higher in the nHA and RALA codelivery groups than the other groups ( Fig.6.D) , suggesting an increased chondrogenic potential of these vectors and pDNA combinations.
The biochemical analysis of the pellets at 21 days of culture showed significantly higher levels of GAG (Fig.6 .E) and collagen ( Fig.6 .F) accumulation following RALA and nHA-mediated delivery of pBMP2 and co-delivery of pTGF-β3-pBMP2 in comparison to PEI-mediated delivery of the same genes.
Histological examination of the pellets after 21 days of in vitro culture demonstrated higher accumulation of GAG and collagen type II deposition, as markers of chondrogenesis, in the nHApBMP2, nHA-pTGF-pBMP, RALA-pBMP2 and RALA-pTGF-pBMP groups (Fig.7.B and D) . Within nHA and RALA transfected MSCs, staining for these cartilage specific markers was most intense following the co-delivery of TGF-β3 and BMP-2. Small nodules of mineral were observed in the pellets generated using nHA transfected MSCs (Fig.7.B) , except in the nHA-pTGF-pBMP2 group despite the fact that this tissue stained intensely for collagen type X, a marker of chondrocyte hypertrophy [47] (Fig.7.B) .
Staining for collagen type X was also detected in the nHA-pBMP2 and RALA-pBMP2 groups (Fig.7.B and D). The PEI treated groups did not stain positively for GAG, calcium, collagen type II or collagen type X deposition ( Fig.7.C) . Collagen type I staining was also more intense in the pellets generated using nHA-BMP2 and nHA-TGF-BMP transfected MSCs (Fig.7B) , but it was also present in the RALA-BMP2, RALA-TGF-BMP (Fig.7.D) and PEI-pBMP2 groups (Fig.7.C) .
DISCUSSION
The overall aim of this study was to investigate the influence of different types of non-viral gene delivery vectors on modulating stem cell fate after the delivery of pDNA encoding for specific genes of interest. Three delivery vectors, PEI, nHA and the RALA amphipathic peptide were selected based on their chemistry and mode of action and complexed with either reporter or therapeutic genes. Systematic in vitro analysis were performed to evaluate the influence of the vectors and gene combinations on MSC fate. Even though the transfection efficiencies of these three vectors were comparable, they exerted unique effects on the metabolic activity, cellular morphology and the phenotype of MSCs. When maintained in mixed osteo-adipo media, MSCs underwent osteogenesis following transfection with nHA and RALA delivery vectors (complexed to reporter genes), and adipogenesis when transfected with PEI. In order to understand the influence of the delivery vector when complexed with therapeutic genes, we next evaluated the delivery of pDNA encoding for the growth factors TGF-β3 and BMP2, in combination or in isolation, on MSC differentiation. nHA, despite promoting significantly lower transgene expression than the other vectors, induced more robust osteogenesis in 2D and accelerated MSC hypertrophy and endochondral ossification in 3D pellet culture. On the contrary, RALA-mediated gene delivery appeared less osteogenic in both 2D and 3D culture, promoting significantly higher expression of chondrogenic markers and a more stable hyaline cartilage-like phenotype in pellet culture. The PEI treated MSCs failed to undergo either osteogenesis or chondrogenesis in 2D and 3D pellet culture despite high levels of therapeutic protein production.
Size, shape and surface charge have been shown to be crucial for internalization and intracellular trafficking of nanoparticle-based drug delivery systems [48, 49] . Cationic nanoparticles of a size in the 10-200 nm range have been identified as the ideal to efficiently overcome physiological and cellular barriers [50, 51] . But successful delivery of nucleic acids using PEI and chitosan complexes bigger than 500 nm and negatively charged lipoplexes and ceramic nanoparticles has also been previously reported [26, 27, 52, 53] . In this study, three different vectors with different size, surface charge and chemistry were used (Fig.1) . PEI and RALA were shown to have a positive Z potential (Fig.1.B) due to the cationic amino groups in PEI and the guanidinium groups present in the peptide's arginine amino acids, which allow them to react with the negatively charged phosphate groups in pDNA [30, 54, 55] (graphical abstract) to form a vector-pDNA complex with a size lower than 150 nm (Fig.1.A, C and E) . nHA nanoparticles possessed a negative zeta potential (Fig.1.B ) and a size of approximately 200-300 nm (Fig.1.A and D) after complexing with pDNA due to particle aggregation caused by the interactions between the calcium ions in the apatite and the anionic phosphate groups in the pDNA [26, 56] (graphical abstract). The charge and size of the nHA nanoparticles and nHA-pDNA complexes were consistent with previous reports [26, 27] .
Even though the RALA, nHA and PEI complexes showed different chemical and physical characteristics, similar transfection efficiencies were observed after 3 days of treatment (Fig.2.A) . PEI associated cytotoxicity has been previously described due to membrane and cellular organelles destabilization [57] , actin cytoskeleton disruption [57] [58] [59] and an altered gene transcription [57, 60, 61] . In this study, a significant decrease in cell metabolic activity was observed in the PEI-pGFP treated group one day after transfection due to polymer-induced cytotoxicity, but this was temporary as metabolic activity recovered by day 3 (Fig.2.B) , as seen in previous reports [22, 35] . The hypothesized PEI-induced cytoskeleton and membrane alterations may affect the transfected MSCs, promoting a more rounded cell morphology with a less tense and organized actin cytoskeleton that is more conducive to adipogenesis [61] [62] [63] [64] . These observations are consistent with previous reports by Godbey et al. [61] who observed that cells exposed to PEI-pDNA complexes showed a rounded phenotype 8 h post-transfection. On the contrary, nHA transfected cells showed a more spread morphology (Fig.2.F) with well-developed stress fibres (Fig.3.B and F) . This may be due to the anionic Z potential of the nHA-pDNA complexes, which have been shown to induce actin polymerization [65] and an increased concentration of intracellular calcium which plays an important role in cell spreading and cytoskeletal events [66] . Although the cell aspect ratio and surface area of the RALA-pGFP transfected cells was significantly lower than the nHA-pGFP group at day 1 and 3, these parameters were higher in comparison to the PEI-transfected cells in both time points (Fig.2.D and F) . CPPs have been previously shown to induce actin remodeling and a selective activation of Rho GTPases [67, 68] contributing to focal adhesion and stress fiber formation [68, 69] , which play an important role in shape-dependent control of MSC lineage commitment [64] .
It is well established that morphology, cytoskeletal tension and focal adhesions have a determinant influence on stem cell differentiation towards the osteogenic, adipogenic and chondrogenic pathways [64, 70] . While a spread phenotype is related to an increase in cytoskeletal organization, focal adhesions and osteogenesis of MSCs, a more rounded morphology can be an indication of cytoskeletal disruption and dispersed actin, which can lead to a switch towards the adipogenic pathway [62, [71] [72] [73] . To investigate the role of the observed transfection-induced morphological and cytoskeletal tension changes, the treated MSCs were cultured under osteo-adipo conditions [64] and their commitment towards the osteogenic or adipogenic lineage was analysed. As might be expected for MSCs adopting a more spread morphology with a tenser cytoskeleton, RALApGFP and nHA-pGFP treated cells showed increased mineralization and mineralized nodule formation in comparison to the untransfected control group and the PEI treated group, in which calcification was suppressed (Fig.4.A, C and D) . On the other hand, adipogenesis was significantly higher in the PEIpGFP transfected MSCs were the cells adopted a more rounded morphology (Fig.4.B and E) . Previous studies have also shown that PEI-mediated transfection can suppress mineralization and enhance adipogeneis of stem cells [74] [75].
The ultimate goal of gene delivery in stem cell-based tissue engineering approaches is to direct stem or progenitor cells to differentiate into clinically relevant cell types. In order to achieve this objective, TGF-β3 and BMP2 have been extensively used in gene and protein-mediated strategies for the repair of musculoskeletal tissues [76] [77] [78] [79] [80] . In this study the delivery of pDNAs encoding for either or both of these factors was used to assess vector-associated effects over stem cell fate. In 2D culture, in the absence of osteogenic supplements, nHA was the only vector capable of inducing mineralization of MSCs when pDNA encoding for either TGF-β3 and BMP2 were delivered in isolation or combination (Fig.5.C and D) . Interestingly, this occurs despite the fact that nHA-mediated transfection resulted in the lowest levels of therapeutic growth factor production (Fig.5.A and B) , suggesting a synergistic effect between the osteogenic stimulus provided by nHA and the overexpressed proteins [26, 76] . Of relevance to this study, Curtin et al. evaluated PEI and nHA as gene carriers for bone formation and observed that even though PEI-mediated transfection of pBMP2 and pVEGF led to higher levels of protein expression, a better healing profile was observed in vivo when nHA was used [8] . These results suggest that high levels of expression may not directly translate into an increased osteogenic effect and that the choice of delivery vector influences the bioactivity of the gene product [15] .
Chondrogenic differentiation of transfected MSCs was also analysed. RALA-mediated delivery of pBMP2 and co-delivery of pTGF-β3 and pBMP2 resulted in the promotion of a stable hyaline cartilage-like phenotype in pellet culture, with strong staining for GAG and collagen type II deposition (Fig.7.D) , and significantly higher expression of the chondrogenic markers ACAN and SOX9 (Fig.6.A and B). MSCs treated with nHA complexed to pTGF-β3 and pBMP2 in isolation or combination also expressed high levels of SOX9 and ACAN (Fig.6.A and B) and stained strongly for collagen type II, but high levels of collagen type X and calcium deposition suggest chondrocyte hypertrophy and progression along an endochondral pathway (Fig.7.B ) [47] . This is likely due, at least in part, to the osteo-inductive nature of the nHA. The lower levels of TGF-β3 protein production following nHAmediated gene delivery may also play a role in promoting a more endochondral phenotype, as extended growth factor presentation has been associated with a more stable cartilage phenotype [81] . In contrast to the nHA and RALA-transfected cells, the PEI-transfected MSCs promoted low levels of GAG and collagen synthesis (Fig.6 .E and F) and failed to induce collagen type II deposition (Fig.7.C) , despite high levels of TGF-β3 and BMP2 expression. The observation of a more rounded phenotype of the cells treated with PEI in 2D (Fig.2 .E) might suggest a propensity towards chondrogenic differentiation [82] , but in this study PEI-mediated transfection failed to promote robust chondrogenesis of MSCs in pellet culture. This might be due to an altered gene transcription produced by the interaction of polycationic polymers with the host DNA upon nuclear entry [60, 61] . The codelivery of pTGF-β3 and pBMP2 by either RALA or nHA promoted the highest levels of chondrogenesis. Furthermore, it was observed that a suppression of calcification and a decrease in RUNX2 expression when both genes were delivered in combination in comparison to the delivery of pTGF-β3 and pBMP2 in isolation (Fig.6.C) . This is consistent with previous studies that show a synergistic effect of delivering both growth factors on chondrogenesis of MSCs [76, 77] .
CONCLUSION
This study demonstrates that different classes of commonly used non-viral vectors are not inert and that the chemical and physical characteristics of these nanomaterials have a strong effect on cell morphology, stress fiber formation and gene transcription in MSCs which modulates their capacity to differentiate along the osteogenic, adipogenic and chondrogenic lineages. Furthermore, the inherent effects associated with the intracellular delivery of these nanoparticle complexes was in many cases more potent than that associated with the overexpressed therapeutic genes, emphasizing the importance of understanding the cellular events upon nanoparticle entry before these approaches are used in tissue engineering and regenerative medicine strategies. The results of this study point to the need for careful and tissue-specific selection of non-viral delivery vectors to prevent undesired phenotypic changes and off-target effects when delivering therapeutic genes to damaged or diseased tissues. 
